While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.